223 related articles for article (PubMed ID: 10674608)
1. Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia.
Ireland AP; Shibata DK; Chandrasoma P; Lord RV; Peters JH; DeMeester TR
Ann Surg; 2000 Feb; 231(2):179-87. PubMed ID: 10674608
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity and immunohistochemistry of adenocarcinomas of the esophagus and gastric cardia.
Marsman WA; Birjmohun RS; van Rees BP; Caspers E; Johan G; Offerhaus A; Bosma PJ; Jan J; van Lanschot B
Clin Cancer Res; 2004 Dec; 10(24):8479-85. PubMed ID: 15623628
[TBL] [Abstract][Full Text] [Related]
3. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
[TBL] [Abstract][Full Text] [Related]
4. Detection of Barrett's adenocarcinoma of the gastric cardia with sucrase isomaltase and p53.
Iannettoni MD; Lee SS; Bonnell MR; Sell TL; Whyte RI; Orringer MB; Beer DG
Ann Thorac Surg; 1996 Nov; 62(5):1460-5; discussion 1465-6. PubMed ID: 8893584
[TBL] [Abstract][Full Text] [Related]
5. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas.
van Dekken H; Geelen E; Dinjens WN; Wijnhoven BP; Tilanus HW; Tanke HJ; Rosenberg C
Cancer Res; 1999 Feb; 59(3):748-52. PubMed ID: 9973227
[TBL] [Abstract][Full Text] [Related]
6. p53 mutations in esophageal tumors from high-incidence areas of China.
Liang YY; Estève A; Martel-Planche G; Takahashi S; Lu SH; Montesano R; Hollstein M
Int J Cancer; 1995 May; 61(5):611-4. PubMed ID: 7768632
[TBL] [Abstract][Full Text] [Related]
7. Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardia.
Gleeson CM; Sloan JM; McManus DT; Maxwell P; Arthur K; McGuigan JA; Ritchie AJ; Russell SE
Br J Cancer; 1998; 77(2):277-86. PubMed ID: 9460999
[TBL] [Abstract][Full Text] [Related]
8. p53 abnormalities in adenocarcinoma of the gastric cardia and antrum.
Fléjou JF; Gratio V; Muzeau F; Hamelin R
Mol Pathol; 1999 Oct; 52(5):263-8. PubMed ID: 10748875
[TBL] [Abstract][Full Text] [Related]
9. P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.
Schneider PM; Stoeltzing O; Roth JA; Hoelscher AH; Wegerer S; Mizumoto S; Becker K; Dittler HJ; Fink U; Siewert JR
Clin Cancer Res; 2000 Aug; 6(8):3153-8. PubMed ID: 10955797
[TBL] [Abstract][Full Text] [Related]
10. Expression of p53 protein in Barrett's adenocarcinoma and adenocarcinoma of the gastric cardia and antrum.
Jovanović I; Todorović V; Milosavljević T; Micev M; Pesko P; Bjelović M; Mouzas Y; Tzardi M
Vojnosanit Pregl; 2005 Dec; 62(12):879-85. PubMed ID: 16375215
[TBL] [Abstract][Full Text] [Related]
11. [Mutation of p53 gene in human cancers of the esophagus and gastric cardia].
Li HC; Lu SX
Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):172-6. PubMed ID: 7956692
[TBL] [Abstract][Full Text] [Related]
12. High frequency of Ki-ras amplification and p53 gene mutations in adenocarcinomas of the human esophagus.
Galiana C; Lozano JC; Bancel B; Nakazawa H; Yamasaki H
Mol Carcinog; 1995 Dec; 14(4):286-93. PubMed ID: 8519418
[TBL] [Abstract][Full Text] [Related]
13. Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China.
Wang LD; Zheng S; Zheng ZY; Casson AG
World J Gastroenterol; 2003 Jun; 9(6):1156-64. PubMed ID: 12800215
[TBL] [Abstract][Full Text] [Related]
14. Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases.
Schneider PM; Casson AG; Levin B; Garewal HS; Hoelscher AH; Becker K; Dittler HJ; Cleary KR; Troster M; Siewert JR; Roth JA
J Thorac Cardiovasc Surg; 1996 Feb; 111(2):323-31; discussion 331-3. PubMed ID: 8583805
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the p53 tumor suppressor gene product in esophageal and gastric carcinomas.
Fléjou JF; Muzeau F; Potet F; Lepelletier F; Fékété F; Hénin D
Pathol Res Pract; 1994 Dec; 190(12):1141-8. PubMed ID: 7540752
[TBL] [Abstract][Full Text] [Related]
16. Comparison of loss of heterozygosity and microsatellite instability in adenocarcinomas of the distal esophagus and proximal stomach.
Yanagi M; Keller G; Mueller J; Walch A; Werner M; Stein HJ; Siewert JR; Höfler H
Virchows Arch; 2000 Dec; 437(6):605-10. PubMed ID: 11193471
[TBL] [Abstract][Full Text] [Related]
17. Relationship between p53 expression and gastric cancers in cardia and antrum.
Azarhoush R; Keshtkar AA; Amiriani T; Kazemi-Nejad V
Arch Iran Med; 2008 Sep; 11(5):502-6. PubMed ID: 18759514
[TBL] [Abstract][Full Text] [Related]
18. p53 Mutations in carcinoma of the esophagus and gastroesophageal junction.
Sengpiel C; König IR; Rades D; Noack F; Duchrow M; Schild SE; Ludwig D; Homann N
Cancer Invest; 2009 Jan; 27(1):96-104. PubMed ID: 19160092
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective study.
Casson AG; Evans SC; Gillis A; Porter GA; Veugelers P; Darnton SJ; Guernsey DL; Hainaut P
J Thorac Cardiovasc Surg; 2003 May; 125(5):1121-31. PubMed ID: 12771886
[TBL] [Abstract][Full Text] [Related]
20. Is Barrett's metaplasia the source of adenocarcinomas of the cardia?
Clark GW; Smyrk TC; Burdiles P; Hoeft SF; Peters JH; Kiyabu M; Hinder RA; Bremner CG; DeMeester TR
Arch Surg; 1994 Jun; 129(6):609-14. PubMed ID: 8204035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
